Osaic Holdings
NEOS

Osaic Holdings’s Neos Therapeutics, Inc NEOS Stock Holding History

Osaic Holdings’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-400
Closed – – 6735
2020
Q3 		$0 Hold
400
– – ﹤0.01% 6551
2020
Q2 		$0 Sell
400
-3,990
-91% -$3.16K ﹤0.01% 6469
2020
Q1 		$4K Buy
+4,390
New +$6.03K ﹤0.01% 5490

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osaic Holdings's NEOS Position: Q4 2020 in Review

Osaic Holdings sold out of Neos Therapeutics, Inc (NEOS) in Q4 2020, closing a stake of 400 shares.

Osaic Holdings first reported a position in NEOS in Q1 2020 and held it in 3 quarters. The position peaked at $4K in Q1 2020. 37 funds tracked by Wall St. Rank hold NEOS as of Q4 2020.

  • Osaic Holdings reported no remaining Neos Therapeutics, Inc position as of Q4 2020 after selling out during the quarter.
  • Osaic Holdings sold 400 Neos Therapeutics, Inc shares in Q4 2020.
  • Osaic Holdings first reported a position in Neos Therapeutics, Inc in Q1 2020 and held it in 3 quarters.
  • Osaic Holdings's Neos Therapeutics, Inc position peaked at $4K in Q1 2020.
  • 37 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2020.

Based on Osaic Holdings's 13F filing for Q4 2020, filed 10 Feb 2021.